Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Journal of Cell Science
|
October 21, 2004
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations
Carole Crozet, Yea-Lih Lin, Clément Mettling, et al.
Clinical Immunology (Orlando, Fla.)
|
May 9, 2009
CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C
Pascal Perney, Chrystell Turriere, Pierre Portalès, et al.
Pathogens (Basel, Switzerland)
|
March 28, 2026
Different Trends of Immune Activation Markers When Switching to Either Oral or Injectable Dual Antiretroviral Therapy Based on Integrase Inhibitors in People Living with HIV
Matteo Vassallo, Jacques Durant, Roxane Fabre, et al.
Clinical Immunology (Orlando, Fla.)
|
March 17, 2007
Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes
Caroline Desmetz, Yea-Lih Lin, Clément Mettling, et al.
AIDS (London, England)
|
June 23, 2006
The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling
Yea-Lih Lin, Clément Mettling, Pierre Portalès, et al.
Current Research in Microbial Sciences
|
November 29, 2021
Meconial <i>Methanobrevibacter smithii</i> suggests intrauterine methanogen colonization in preterm neonates
Youssouf Sereme, Cheick Oumar Guindo, Anne Filleron, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 24, 2010
High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection
Anne-Laure Fiser, Thierry Vincent, Natalie Brieu, et al.
Immunology
|
September 11, 2009
Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody
Pierre Portalès, Sylvie Fabre, Thierry Vincent, et al.
BMC Nephrology
|
April 23, 2020
Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study
Valerie Olivier, Catherine Dunyach-Remy, Pierre Corbeau, et al.
Rheumatology (Oxford, England)
|
August 12, 2021
CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis
Claire Rempenault, Julie Mielle, Kristina Schreiber, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Journal of Cell Science
|
October 21, 2004
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations
Carole Crozet, Yea-Lih Lin, Clément Mettling, et al.
Clinical Immunology (Orlando, Fla.)
|
May 9, 2009
CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C
Pascal Perney, Chrystell Turriere, Pierre Portalès, et al.
Pathogens (Basel, Switzerland)
|
March 28, 2026
Different Trends of Immune Activation Markers When Switching to Either Oral or Injectable Dual Antiretroviral Therapy Based on Integrase Inhibitors in People Living with HIV
Matteo Vassallo, Jacques Durant, Roxane Fabre, et al.
Clinical Immunology (Orlando, Fla.)
|
March 17, 2007
Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes
Caroline Desmetz, Yea-Lih Lin, Clément Mettling, et al.
AIDS (London, England)
|
June 23, 2006
The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling
Yea-Lih Lin, Clément Mettling, Pierre Portalès, et al.
Current Research in Microbial Sciences
|
November 29, 2021
Meconial <i>Methanobrevibacter smithii</i> suggests intrauterine methanogen colonization in preterm neonates
Youssouf Sereme, Cheick Oumar Guindo, Anne Filleron, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 24, 2010
High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection
Anne-Laure Fiser, Thierry Vincent, Natalie Brieu, et al.
Immunology
|
September 11, 2009
Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody
Pierre Portalès, Sylvie Fabre, Thierry Vincent, et al.
BMC Nephrology
|
April 23, 2020
Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study
Valerie Olivier, Catherine Dunyach-Remy, Pierre Corbeau, et al.
Rheumatology (Oxford, England)
|
August 12, 2021
CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis
Claire Rempenault, Julie Mielle, Kristina Schreiber, et al.
Page
of 7